true

Swan-Ganz™ Pulmonary Artery Catheters

The most trusted name in right heart monitoring

Continuous view of cardiac function in your most  complex patients

The first flow-directed Swan-Ganz™ Pulmonary Artery Catheter revolutionized haemodynamic monitoring in critically-ill patients. Utilizing continuous data, Swan-Ganz™ Pulmonary Artery Catheters track your patient’s haemodynamic status to assist your early evaluation.

Reimagine right heart monitoring with Swan-Ganz IQ™ Catheter

Continuous right ventricular cardiac output (CO_RV)

Uses a smart algorithm to provide continuous right ventricular cardiac output (CO_RV) that updates every 10 seconds

Global Hypoperfusion Index (GHI) parameter

Predicts mixed venous desaturations up to 15 minutes in advance*

^{*Defined as SvO₂ of ≤60% for at least one minute.}

Right ventricular pressure (RVP)

Provides continuous insights into right ventricular function

Smart Wedge

Assesses the quality of a pulmonary artery occlusion pressure (PAOP) measurement

See a comprehensive picture of right heart function

When used with HemoSphere Alta™ Monitor, Swan-Ganz IQ™ Catheter enables continuous monitoring that provides a comprehensive picture of your patient's right heart function—along with exclusive access to innovative parameters.

Explore HemoSphere Alta™ Monitor

Right heart monitoring, reimagined

Building on more than 50 years of innovation, Swan-Ganz IQ™ Catheter leads the next generation of pulmonary artery catheter technology. We’ve innovated on the technology you trust to bring you faster insights into haemodynamic instability and support earlier interventions.

Smart insights for faster interventions

Swan-Ganz IQ™ Catheter applies a smart algorithm to analyze the RVP waveform and deliver continuous cardiac output (CO_RV) that updates every 10 seconds.

CO_RV enables clinicians to see changes in haemodynamic status and responses to interventions sooner—providing dynamic decision support during critical moments.

Assess SvO₂ and CO_RV in sync

With Swan-Ganz IQ™ Catheter, SvO₂ and CO_RV measurements update closely in sync, helping you confidently assess changes in the balance of oxygen delivery and consumption.

Confirm wedge quality for confident clinical decisions

Smart Wedge measures pulmonary artery occlusion pressure (PAOP) and assesses the quality of the PAOP measurement—helping clinicians make confident clinical decisions based on a high-quality wedge measurement.^†

_{^†Smart Wedge is available with all Swan-Ganz™ Catheters on HemoSphere Alta™ Monitor.}

A comprehensive haemodynamic profile in a single catheter

Swan-Ganz™ Advanced Technology Pulmonary Artery Catheters enable continuous assessment of flow, pressure and oxygen delivery and consumption, so you have an uninterrupted view of cardiac function and proactive decision support in your most complex patients. Access a comprehensive haemodynamic profile delivered by a single catheter to help you assess cardiovascular function and guide treatment decisions.

Target complex patient conditions with advanced haemodynamic parameters

For a continuous view of cardiac function that can enable earlier intervention, choose the catheter with the parameters that best suit your clinical approach and your patient’s needs. Swan-Ganz™ Catheter allows continuous monitoring of the balance of oxygen delivery and consumption with these advanced haemodynamic parameters:

PARAMETERS: SvO₂ | CCO | SV | SVR | RVEF | RVEDV | PAP | RAP | PAOP

Continuous cardiac output (CCO)

Swan-Ganz™ Advanced Technology Catheters offer CCO, which continuously monitors cardiac output with the ability to:

Access continuous calculation and display of cardiac output on CCO thermodilution catheters.
Use thermal energy to calculate cardiac output using thermodilution principles on HemoSphere™ and HemoSphere Alta™ Monitor.
Measure cardiac output using the traditional bolus thermodilution method.

Mixed venous oxygen saturation (SvO₂)

Swan-Ganz™ Oximetry Catheters allow for the continuous monitoring of SvO₂, which updates every 2 seconds to assess the balance between oxygen delivery and consumption. Since SvO₂ is a sensitive indicator of patient status and generally precedes other indications of cardiopulmonary instability, continuous SvO₂ monitoring may allow diagnostic and therapeutic decisions to be made earlier in the patient's clinical course.

Thermodilution pulmonary artery catheters

Swan-Ganz™ Thermodilution Catheters monitor intracardiac pressures and cardiac output, along with providing infusing solutions.

When used with a compatible monitor, Swan-Ganz™ Thermodilution Catheters enable you to:

Assess haemodynamic condition through direct intracardiac and pulmonary artery pressure monitoring and cardiac output determination.
Sample mixed venous blood through the distal (pulmonary artery) port for the assessment of oxygen transport balance and the calculation of derived parameters such as oxygen consumption, oxygen utilization coefficient, and intrapulmonary shunt fraction.
Infuse using an extra lumen with proximal port (30 cm) on Swan-Ganz™ VIP Catheters, in addition to the standard distal and injectate lumens, to provide direct access to the right atrium.

PARAMETERS: iCO | PAP | RAP | PAOP

CO-Set+ closed injectate delivery system

CO-Set+ closed injectate delivery system works effectively with room temperature or cold injectate for the measurement of bolus thermodilution cardiac output when used with a compatible monitoring platform and Swan-Ganz™ Catheter.

In-line temperature probe is directly in the injectate fluid path.
Volume-limited syringe (10 cc) aids in obtaining reproducible cardiac output by simplifying filling and eliminating the variability from differences in filling techniques.
The syringe plunger and the finger grips on the syringe jacket have been designed to help accommodate a wide range of user hand sizes for efficient and comfortable injection of fluid.

Tissue oximetry and right heart monitoring

When using ForeSight IQ™ Tissue Oximetry Sensors and Swan-Ganz IQ™ Catheter simultaneously, you can understand the adequacy of regional oxygen delivery and monitor cardiac output, which is one of the primary determinants of oxygen delivery.

Individualize care with multi-sensor monitoring

Trend multiple compatible sensors together for a comprehensive view of haemodynamics, so you can understand and treat the source of haemodynamic instability.

Monitor pressures and cardiac outputs from the left and right heart to gain comprehensive insights for your most complex, vulnerable patients.

Continuously monitor the brain, left heart and right heart together in one comprehensive view.

Enable individualized care with full-range cuff, sensor and catheter compatibility.

Advance patient care with ongoing education

BD Advanced Patient Monitoring is here to help you stay on top of the latest clinical challenges and make the most of haemodynamic monitoring solutions.

Explore Resource Library

true

GARAN ET AL, 2020

Complete hemodynamic profiling with pulmonary artery catheters in cardiogenic shock is associated with lower in-hospital mortality

Objective: Explore the potential benefit of obtaining a complete haemodynamic profile via pulmonary artery catheters (PAC) prior to administration of mechanical circulatory support (MCS) in cardiogenic shock (CS) patients.

Results: The study observed that CS patients with complete PAC data obtained prior to MCS had improved survival compared to those who did not, along with other benefits including:

Lower mortality in patients with advanced stages of CS
Lowest in-hospital mortality across study sub-groups and Society of Cardiovascular Angiography and Interventions (SCAI) stages
Early identification of haemodynamic compromise
An incomplete haemodynamic dataset is equivalent to having no PAC data

Read study in the Journal of the American College of Cardiology: Heart Failure

SHAW ET AL, 2018

Pulmonary artery catheter use in adult patients undergoing cardiac surgery: a retrospective, cohort study

Objective: To examine the utility of PAC in complex cardiac surgeries, and their association with subsequent clinical outcomes including 30-day in-hospital mortality, major morbidity, and length of stay.

Results: The study concluded PAC use did not contribute to in-hospital mortality and could be associated with a statistically significant decrease in length of hospital stay and a significant decrease in the cardiopulmonary morbidity composite: